AU4581200A - Protease activated receptor 2 variants - Google Patents

Protease activated receptor 2 variants Download PDF

Info

Publication number
AU4581200A
AU4581200A AU45812/00A AU4581200A AU4581200A AU 4581200 A AU4581200 A AU 4581200A AU 45812/00 A AU45812/00 A AU 45812/00A AU 4581200 A AU4581200 A AU 4581200A AU 4581200 A AU4581200 A AU 4581200A
Authority
AU
Australia
Prior art keywords
par
polypeptide
receptor
amino acid
agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45812/00A
Other languages
English (en)
Inventor
Jennifer Ann Cairns
Steven John Compton
Alan Charles Gough
Karen-Jane Palmer
Andrew Finlay Walls
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southampton
Original Assignee
University of Southampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southampton filed Critical University of Southampton
Publication of AU4581200A publication Critical patent/AU4581200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU45812/00A 1999-04-15 2000-04-17 Protease activated receptor 2 variants Abandoned AU4581200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9908513.6A GB9908513D0 (en) 1999-04-15 1999-04-15 Molecular cloning of a new DNA sequence for protease activated receptor 2
GB9908513 1999-04-15
PCT/GB2000/001455 WO2000063371A1 (en) 1999-04-15 2000-04-17 Protease activated receptor 2 variants

Publications (1)

Publication Number Publication Date
AU4581200A true AU4581200A (en) 2000-11-02

Family

ID=10851510

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45812/00A Abandoned AU4581200A (en) 1999-04-15 2000-04-17 Protease activated receptor 2 variants

Country Status (7)

Country Link
EP (1) EP1165790A1 (es)
JP (1) JP2002541843A (es)
AU (1) AU4581200A (es)
CA (1) CA2370272A1 (es)
GB (1) GB9908513D0 (es)
MX (1) MXPA01010380A (es)
WO (1) WO2000063371A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0213286D0 (en) * 2002-06-10 2002-07-24 Univ Edinburgh Par-2-Activating peptide derivative and pharmaceutical composition using the same
FR2841559A1 (fr) * 2002-06-28 2004-01-02 Pfizer Recepteurs par modifies, preparation et utilisations
GB2450747A (en) * 2007-07-06 2009-01-07 Univ Sheffield Treatment of sensorineural hearing loss
WO2012090207A2 (en) * 2010-12-30 2012-07-05 Hadasit Medical Research Services & Development Limited Par1 and par2 c-tail peptides and peptide mimetics
CN113795505A (zh) * 2019-05-03 2021-12-14 詹森生物科技公司 Par2调节及其方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716789A (en) * 1993-07-26 1998-02-10 Cor Therapeutics, Inc. Method to determine ligands, agonist and antagonist of C140 receptor

Also Published As

Publication number Publication date
CA2370272A1 (en) 2000-10-26
EP1165790A1 (en) 2002-01-02
MXPA01010380A (es) 2003-07-21
GB9908513D0 (en) 1999-06-09
WO2000063371A1 (en) 2000-10-26
JP2002541843A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
JP4411330B2 (ja) 腫瘍壊死因子関連リガンド
US5886153A (en) Antibodies directed against the alpha interferon receptor
WO2005084116A2 (en) Calcium channel variants
AU7608898A (en) Ntn-2 member of tnf ligand family
JPH07509613A (ja) インターロイキン−１０（ｉｌ−１０）のための哺乳類レセプター
WO1993021302A1 (en) Cadherin materials and methods
AU2001284977A1 (en) Claudin polypeptides
US7972813B2 (en) Tetrodotoxin-resistant sodium channel alpha subunit
WO2002014499A9 (en) Claudin polypeptides
US20030180739A1 (en) Reagents and methods for identifying gene targets for treating cancer
US20080009004A1 (en) Claudin polypeptides, polynucleotides, and methods of making and use thereof
WO2001012658A2 (en) Human icos ligand and application thereof
NO314848B1 (no) Protein for inhibering av kollagenfremkalt blodplateaggregering, DNA som koder for proteinet, vektor som omfatter et slikt DNA, vertscelletransformert medvektoren, fremgangsmåter for fremstilling og rensing avproteinet, farmasöytiskpreparat
AU4581200A (en) Protease activated receptor 2 variants
JPH10150993A (ja) 新規ｇ−蛋白結合受容体ｈｌｔｅｘ１１
JP2001514886A (ja) Ｃｃｒ２遺伝子のミスセンス対立遺伝子によるａｉｄｓへの進行の遅延
JP2012061008A (ja) Ｐ−糖タンパク質およびその使用
US20040038370A1 (en) Claudin polypeptides
WO1998033819A9 (en) Cellular receptors for subgroup c adenoviruses and group b coxsackieviruses
CA2316545A1 (en) Novel nucleic acid and polypeptide with homology to the tnf-receptors
US20050169917A1 (en) Orphanin FQ receptor
CA2410525A1 (en) Fas ligand-fused proteins
US6812336B1 (en) Transcription factor coactivator protein, p/CIP
WO1999037769A1 (en) Orphan receptors
JPH0827190A (ja) コレシストキニン−ｂ／ガストリン受容体蛋白及び遺伝子